Multiple successful 16,000L PPQ runs highlight that disposable manufacturing can achieve similar performance as traditional stainless reactors GMP Authorizations by HPRA demonstrate that new global sites have built strong world-class regulatory and quality system DUNDALK, […]
Tag: WuXi Biologics
WuXi Biologics Achieves Major Milestones at Ireland Site with Multiple 16,000L PPQ Success and HPRA GMP Authorizations
Multiple successful 16,000L PPQ runs highlight that disposable manufacturing can achieve similar performance as traditional stainless reactors GMP Authorizations by HPRA demonstrate that new global sites have built strong world-class regulatory and quality system DUNDALK, […]
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development
SHANGHAI, Oct. 28, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia™ RidGS, a high-yield glutamine synthetase (GS)-knockout Chinese hamster […]
WuXi Biologics Included in Hang Seng ESG 50 Index
HONG KONG, Sept. 23, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has been included in the Hang Seng ESG 50 […]
WuXi Biologics Effectively Completes First Scale-Up of Top-Productiveness Bioprocessing Platform WuXiUI™ in 2,000L GMP Production
WuXi Biologics Achieves Milestone in 2,000L Drug Substance Production WuXi Biologics, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), recently announced a significant achievement in biologics manufacturing. Through the utilization of its ultra-intensified fed-batch […]
